Cg. Chen et al., TRANSGENIC EXPRESSION OF HUMAN ALPHA-1,2-FUCOSYL-TRANSFERASE (H-TRANSFERASE) PROLONGS MOUSE HEART SURVIVAL IN AN EX-VIVO MODEL OF XENOGRAFTREJECTION, Transplantation, 65(6), 1998, pp. 832-837
Background. The expression of human alpha 1,2-fucosyltransferase (H-tr
ansferase, HT) has been proposed as an alternative strategy to alpha 1
,3-galactosyltransferase (GT) gene knockout, which is not currently fe
asible in pigs, to reduce the galactose-alpha 1,3-galactose (Gal) epit
ope expression, HT expression has recently been shown in transgenic mi
ce and pigs to significantly reduce Gal expression on a variety of cel
ls; however, its ability to do so on endothelial cells and its effecti
veness at prolonging xenograft survival are yet to be determined. Meth
ods. HT-transgenic, Gal knockout (Gal KO) mice, and mice containing bo
th genetic modifications (HT-transgenic/Gal KO) were tested for II-sub
stance and Gal expression on splenocytes and endothelial cells by flow
cytometric analysis. In addition, the hearts of these mice were perfu
sed ex vivo with 6% human plasma, and the effect on cardiac function w
as determined, Results and Conclusion. H-substance expression was dete
cted on both splenocytes and endothelial cells of HT-transgenic mice,
The level of II-substance expression was not affected by the presence
or absence of GT in the cells, consistent with HT being dominant over
GT, The ability of HT expression to reduce Gal expression was highly v
ariable depending on the cell type, Gal expression on splenocytes was
almost completely eliminated, whereas on endothelial cells, substantia
l Gal remained despite a 70% reduction, When perfused ex vivo with hum
an plasma, hearts from HT-transgenic, Gal KO, and HT-transgenic/Gal KO
mice demonstrated a similar prolongation in survival, compared with w
ild-type controls, Therefore, as far as hyperacute rejection is concer
ned, HT expression may be as effective as Gal KO in protecting against
xenoantibody and complement mediated injury, However, the effect of r
esidual Gal on non-hyperacute rejection responses remains to be determ
ined.